RankAlpha logo
Back to Rankings

ENLV

EnlivexA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Curated Events
1
Active
Recent Headlines
0
New
Recent news sentiment
0.0
30-day score
Company
-
30-day
Macro
-
30-day
Pulse
-
30-day
Weekly research
-
10-day

Curated events

Materiality
72
capital return
Source
External coverage
Decided
2026-05-24
Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program

Enlivex paired a $21 million debt financing with a $20 million share repurchase program and token-related updates. The buyback is a supportive capital-return signal, but the new debt and mixed non-core updates make the net read-through only mildly positive and still somewhat unclear.

View event details

Sentiment decomposition

0.0
30-day score
Company-55%
Macro-30%
Pulse-15%
Weekly research-10-day
Company, Macro, and Pulse form the existing 30-day artifact blend. Weekly research is tracked separately for 10 days and can contribute at most 10% of the sentiment pillar when live mode is enabled.

Recent headlines

No supplemental ticker headlines stored yet

We are still collecting relevant articles for ENLV. Curated events highlight the most material developments impacting this ticker right now.

Check curated eventsOpen full news archive
As of 2026-05-24 • Updated scheduledSource: News desk